RENASCOR CLINICAL RESEARCH Trademark

Trademark Overview

On Thursday, January 2, 2025, a trademark application was filed for RENASCOR CLINICAL RESEARCH with the United States Patent and Trademark Office. The USPTO has given the RENASCOR CLINICAL RESEARCH trademark a serial number of 98933956. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Saturday, March 28, 2026. This trademark is owned by RENASCOR CLINICAL RESEARCH. The RENASCOR CLINICAL RESEARCH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research
renascor clinical research

General Information

Serial Number98933956
Word MarkRENASCOR CLINICAL RESEARCH
Filing DateThursday, January 2, 2025
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateSaturday, March 28, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 29, 2025

Trademark Statements

Goods and ServicesMedical research
NOT AVAILABLE"CLINICAL RESEARCH"
Translation of Words in MarkThe English translation of "RENASCOR" in the mark is "REBORN".

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 2, 2025
Primary Code042
First Use Anywhere DateMonday, September 22, 2025
First Use In Commerce DateMonday, September 22, 2025

Trademark Owner History

Party NameRENASCOR CLINICAL RESEARCH
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRENO, NV 89521
US
Party NameRENASCOR CLINICAL RESEARCH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRENO, NV 89521
US

Trademark Events

Event DateEvent Description
Thursday, January 2, 2025NEW APPLICATION ENTERED
Monday, April 28, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 13, 2025ASSIGNED TO EXAMINER
Tuesday, June 24, 2025EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 24, 2025EXAMINERS AMENDMENT E-MAILED
Tuesday, June 24, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 24, 2025EXAMINER'S AMENDMENT ENTERED
Tuesday, June 24, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 23, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 29, 2025PUBLISHED FOR OPPOSITION
Tuesday, July 29, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 23, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 26, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, November 18, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 18, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 18, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 27, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 18, 2025USE AMENDMENT FILED
Saturday, March 28, 2026STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

research clinical renascor medical